The impact of adipokines on vascular networks in adipose tissue.


Journal

Cytokine & growth factor reviews
ISSN: 1879-0305
Titre abrégé: Cytokine Growth Factor Rev
Pays: England
ID NLM: 9612306

Informations de publication

Date de publication:
02 2023
Historique:
received: 02 06 2022
revised: 21 07 2022
accepted: 21 07 2022
pubmed: 12 8 2022
medline: 8 2 2023
entrez: 11 8 2022
Statut: ppublish

Résumé

Adipose tissue (AT) is a highly active and plastic endocrine organ. It secretes numerous soluble molecules known as adipokines, which act locally to AT control the remodel and homeostasis or exert pleiotropic functions in different peripheral organs. Aberrant production or loss of certain adipokines contributes to AT dysfunction associated with metabolic disorders, including obesity. The AT plasticity is strictly related to tissue vascularization. Angiogenesis supports the AT expansion, while regression of blood vessels is associated with AT hypoxia, which in turn mediates tissue inflammation, fibrosis and metabolic dysfunction. Several adipokines can regulate endothelial cell functions and are endowed with either pro- or anti-angiogenic properties. Here we address the role of adipokines in the regulation of angiogenesis. A better understanding of the link between adipokines and angiogenesis will open the way for novel therapeutic approaches to treat obesity and metabolic diseases.

Identifiants

pubmed: 35953434
pii: S1359-6101(22)00057-0
doi: 10.1016/j.cytogfr.2022.07.008
pii:
doi:

Substances chimiques

Adipokines 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

61-72

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest All authors declare no Conflict of Interest that are directly or indirectly related to the work submitted for publication.

Auteurs

Maria Vliora (M)

FAME Laboratory, Department of Exercise Science, University of Thessaly, Trikala, Greece; Department of Molecular and Translational Medicine, University of Brescia, Via Branze 39, Brescia, Italy.

Cosetta Ravelli (C)

Department of Molecular and Translational Medicine, University of Brescia, Via Branze 39, Brescia, Italy.

Elisabetta Grillo (E)

Department of Molecular and Translational Medicine, University of Brescia, Via Branze 39, Brescia, Italy.

Michela Corsini (M)

Department of Molecular and Translational Medicine, University of Brescia, Via Branze 39, Brescia, Italy.

Andreas D Flouris (AD)

FAME Laboratory, Department of Exercise Science, University of Thessaly, Trikala, Greece.

Stefania Mitola (S)

Department of Molecular and Translational Medicine, University of Brescia, Via Branze 39, Brescia, Italy. Electronic address: stefania.mitola@unibs.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH